Skip to main content

Table 5 Prevalence of PCC at D28+ survey (N = 403)

From: COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center

PCC definition

Prevalence of PCC, n (%)

Definitions based on number of symptoms

PCC Definition 1 (≥ 1 symptom)

277 (68.7%)

PCC Definition 2 (≥ 3 symptoms)

178 (44.2%)

PCC Definition 3 (≥ 5 symptoms)

121 (30.0%)

Definitions based on severity of symptoms

PCC Definition 4 (≥ 1 moderate or severe symptom)

188 (46.5%)

PCC Definition 5 (≥ 2 moderate or severe symptoms)

145 (35.9%)

PCC Definition 6 (≥ 3 moderate or severe symptoms)

93 (23.0%)

  1. Based on 28 days or more post-symptom onset; follow-up times for D28+ survey varied
  2. Original N = 411; calculations exclude 8 patients with time from symptom onset to Day 28 survey < 28 days
  3. PCC post-COVID conditions